China just proved it doesn't need to fire a single bullet to bring Taiwan to its knees...

The superpower has long wanted to bring Taiwan back into its orbit. For years, experts have warned that it might do that through force.

And with just the 110-mile-wide Taiwan Strait between the two, the threat of a Chinese invasion is never far away.

Maybe you're picturing Chinese forces crossing the Taiwan Strait, then storming the island under a hail of missile fire. That could happen...

But that's not the only strategy in China's playbook.

It only needs to severely cripple the island – not subdue it. And it's taking steps in that direction...

China regularly patrols the Taiwan Strait, and it even simulated a blockade of the island last December. In its latest maneuvers, the Chinese coast guard and other ships expanded their operations around eastern Taiwan, the side farthest from the mainland... effectively encircling the island.

Taiwan's coast guard reported a record 244 sightings of vessels from the Chinese government in July – 4 times the number of sightings from the same time last year.

So far, China's armed forces haven't boarded any ships headed to Taiwan. But they have pressured merchant vessels to provide information about when they're entering and leaving Taiwanese ports.

China's coast guard answers directly to the nation's military commanders – it's not a civilian police force. So by ramping up its presence in the waters surrounding Taiwan, China is escalating toward a full maritime blockade.

That would be catastrophic for Taiwan.

You see, as an island nation, Taiwan imports nearly all its energy, including massive shipments of natural gas. A blockade would crush Taiwan's power grid and place immense economic pressure on Taipei.

And the fallout wouldn't stop at Taiwan's borders...

Taiwan is responsible for more than 90% of the world's advanced semiconductor chips. A prolonged disruption would send shockwaves through global supply chains for automobiles, electronics, AI, and even military equipment.

The U.S. can't allow that. Plus, it has previously committed to helping Taiwan defend itself. But American naval forces are already stretched thin by the conflict in the Middle East.

Fighting or deterring multiple threats at once requires immense scale. And the U.S. Navy isn't the fleet it once was.

At the start of last year, the Navy only had 296 battle-force ships. China had more than 370.

Washington recognizes this vulnerability.

To reclaim U.S. maritime dominance, Congress and defense planners are pushing for a massive naval expansion. This includes plans for a 450-ship fleet by 2031.

Money is going to flow into the shipbuilding industry in the coming years and decades. That's inevitable as tension builds in the Pacific.

The White House requested $65.8 billion in the 2027 fiscal year for shipbuilding, up 57% from fiscal 2026.

This should get investors excited...

Investing in a shipbuilder is a logical way to play this. But building warships is a low-margin, capital-intensive business.

My friend and colleague Joel Litman at our corporate affiliate Altimetry knows a better way to take advantage...

You see, every warship depends on thousands of specialized components. So the smaller companies making these them will earn a lot of money in the coming years.

These businesses aren't household names. And because they're so small, they have far greater upside than the massive shipbuilding companies. As trillions of dollars flow into America's defense systems, these stocks could see the largest gains.

Today is the last day to hear Joel's presentation on this fleeting opportunity. Click here to learn more.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
September 30, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top